David Gius receives UT System award to advance research on aging and breast cancer
September 10, 2021
David Gius, MD, PhD, has been awarded a $1.6 million UT System Faculty STARs award to support his research on aging and breast cancer.
Healio News: NIA expands Alzheimer’s disease research center network
September 10, 2021
This Healio News story is about the University of Texas Health Science Center at San Antonio, in partnership with The University of Texas Rio Grande Valley, being named a new National Institute on Aging-designated Alzheimer’s Disease Research Center. Read story
UT Health San Antonio, UT Rio Grande Valley selected as NIA Alzheimer’s Disease Research Center
September 9, 2021
This designation by the National Institute on Aging will be transformational as researchers seek cures and provide the best possible care to families throughout the state.
San Antonio Report: UT Health San Antonio, UT Rio Grande Valley designated Texas’ only national Alzheimer’s research center
September 9, 2021
This San Antonio Report story is about the University of Texas Health Science Center at San Antonio, in partnership with The University of Texas Rio Grande Valley, announcing it has been named a new National Institute on Aging-designated Alzheimer’s Disease Research Center. Read story
UT Health Science Center San Antonio, UT Rio Grande Valley selected as NIA Alzheimer’s Disease Research Center
September 9, 2021
“Glenn would be so pleased that this prestigious NIH Center of Excellence has been awarded to help the families of our region and the state that he loved.” Contact: Will Sansom, (210) 567-2579, Sansom@uthscsa.edu SAN ANTONIO (Sept. 9, 2021) — The University of Texas Health Science Center at San Antonio and The University of Texas […]
Fox 7 Austin: Denver requires city workers in ‘high risk’ areas to get vaccinated
August 3, 2021
Dr. Sudha Seshadri, Neurology/Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, discussed a study of older adults in Argentina that showed a surprising amount of dementia-like changes in memory and thinking for at least six months after contracting COVID-19. Watch story